Nirmatrelvir-ritonavir for Treating COVID-19 Patients: A Case-Control Study
Tania Castillo-Cruz, Daniel López-Hernández, Maria del Rocio Thompson-Bonilla, Antonio Mayoral-Ortiz, Leticia Brito-Aranda, Liliana Grisel Liceaga-Perez, Nallely Blanco-Osorio, Guadalupe Jacqueline Flores-Morales, Edgar Cruz-Aviles, Israel Aguilar-Cozatl, Carlos Ramirez-Velazquez, Luis Manuel Reyes-Perez, Luis Beltra-Lagunes, Liliana Garcia-Montiel, Ulises Cruz-Farias, Xochitl Liliana Olivares-Lopez, Victor Hugo Noguez-Alvarez, Karina Ayala-Lopez, Edgar Esteban Torres-Garcia, Sandy Andrea Saavedra-Contreras & Saul Odin-Rodriguez Ramirez · Current Journal of Applied Science and Technology · 2025
Aims: To compare the efficacy of nirmatrelvir/ritonavir versus symptomatic management in reducing mortality, and clinical severity, and increasing clinical improvement among patients with COVID-19. Study design: A multicentre, retrospective, and case-control study was conducted,...